WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 5 fonti

Nvidia and Genentech make the case for AI-driven drug discovery at BIO2026

Nvidia and Genentech made the case for AI-driven drug discovery at BIO2026, showcasing the BioNeMo toolkit and their multi-year partnership in life

Raccontata daft.comsnowflake.comcryptobriefing.comsiliconangle.comstatnews.com

Confronto fonti

5 prospettive sulla stessa storia
AI · summaries
cryptobriefing.comStai leggendo4 g fa

Nvidia and Genentech make the case for AI-driven drug discovery at BIO2026

Nvidia and Genentech made the case for AI-driven drug discovery at BIO2026, showcasing the BioNeMo toolkit and their multi-year partnership in life

originale

Timeline cronologica

  1. martedì 23 giugno 2026·ft.com

    Nvidia’s Kimberly Powell: We are reinventing the doctor experience

    The chipmaker’s head of healthcare argues AI can ease many of the sector’s ills, including reducing medics’ workload and tackling the shortage of trained staff

  2. martedì 23 giugno 2026·snowflake.com

    Snowflake and NVIDIA Bring Agentic AI to Life Sciences

    Discover how Snowflake and the NVIDIA BioNeMo Agent Toolkit power agentic AI in life sciences with governed workflows, secure data access, and faster R&D.

siliconangle.com
6 g fa

Nvidia bets on agentic AI to turbocharge biotech discovery - SiliconANGLE

Nvidia bets on agentic AI to turbocharge biotech discovery - SiliconANGLE

Leggi questa versione → originale
snowflake.com6 g fa

Snowflake and NVIDIA Bring Agentic AI to Life Sciences

Discover how Snowflake and the NVIDIA BioNeMo Agent Toolkit power agentic AI in life sciences with governed workflows, secure data access, and faster R&D.

Leggi questa versione → originale
ft.com6 g fa

Nvidia’s Kimberly Powell: We are reinventing the doctor experience

Healthcare sector deploys AI 3x faster than others. Nvidia infrastructure enables clinician automation (40% admin reduction) and agent data integration. For CTOs: agent-AI bridging fragmented systems becomes critical to retain clinicians and scale amid global shortage. HIPAA-compliance constrains implementation.

Leggi questa versione → originale
statnews.com4 g fa

At BIO 2026, industry wrestled with Washington politics, and making AI work better

At BIO 2026, executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug price moves.

Leggi questa versione → originale
  • martedì 23 giugno 2026·cryptobriefing.com

    Nvidia unveils BioNeMo agent toolkit for AI-driven drug discovery and biology research

    Nvidia launched the BioNeMo Agent Toolkit at BIO International Convention, bringing agentic AI to drug discovery and diagnostics with early partners already

  • mercoledì 24 giugno 2026·siliconangle.com

    Nvidia bets on agentic AI to turbocharge biotech discovery - SiliconANGLE

    Nvidia bets on agentic AI to turbocharge biotech discovery - SiliconANGLE

  • giovedì 25 giugno 2026·cryptobriefing.com

    Nvidia and Genentech make the case for AI-driven drug discovery at BIO2026

    Nvidia and Genentech made the case for AI-driven drug discovery at BIO2026, showcasing the BioNeMo toolkit and their multi-year partnership in life

  • giovedì 25 giugno 2026·statnews.com

    At BIO 2026, industry wrestled with Washington politics, and making AI work better

    At BIO 2026, executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug price moves.

  • sabato 27 giugno 2026·cryptobriefing.com

    Nvidia invests in Generate Biomedicines, targeting $1.8T market with AI-driven drug discovery

    Nvidia's venture arm NVentures holds 833,325 shares in Generate:Biomedicines, an AI-driven biotech targeting the $1.8 trillion pharmaceutical market.